Considering that gene duplications of the SET1A gene is found in almost half of breast cancer (54,55) and the essential role of Cfp1 in controlling the activity of SET1A/B, our studies may have unraveled a novel pocket for structure-activity relationship studies and the development of small molecules able to disrupt this region of COMPASS. The gene discussed is SETD1A; the disease is breast carcinoma.